Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 2

Review

Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma

       
Total article views   HTML views PDF downloads Totals
10,891 Dovepress* 10,891+ 2,515 13,406
Totals 10,891 2,515 13,406
*Since 21 May 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on Google Scholar